Skip to content
TrialScanner

NCT04333420

Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia

Phase 2/Phase 3CompletedIFRXLead

Registry record

Lead sponsor
InflaRx GmbH
Conditions
Severe COVID-19 Pneumonia
Primary completion
Oct 31, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04333420 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04333420: Randomized, Controlled Study... | TrialScanner